Jupiter Neurosciences, Inc.

• Jupiter Neurosciences, Inc.
• Health Care

JUNS

Offering Team

Pre-IPO Investors

Deal Highlights

Jupiter Neurosciences, Inc. (the “Company”) is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The Company incorporated in Delaware in January 2016. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL™, has many potential indications of use for rare diseases, which of we primarily are targeting Mucopolysaccharidoses Type 1, Friedreich’s Ataxia, and MELAS and with ALS in an early development stage. In the larger disease areas, we are primarily targeting Mild Cognitive Impairment/early Alzheimer’s disease with TBI/concussions and Covid-19 in early development stages. We will have a specifically high focus on the expected positive effect JOTROL™ will have on neuroinflammation in all indications we are pursuing.

Based on available scientific literature, we believe that JOTROL™ is the first and only resveratrol product in the world that delivers a therapeutically effective dose of resveratrol in the blood stream without causing gastrointestinal (GI) side effects. We believe that JOTROL™ is a safe oral medication, based on existing documented safety profile of resveratrol and the results from our Phase I study which did not result in any serious adverse events. JOTROL™, based on our pre-clinical and Phase I study results, delivers resveratrol into the blood plasma with significantly greater bioavailability than conventional resveratrol and has the ability to cross the blood-brain barrier, where it has, in studies conducted in Friedreich’s ataxia (FA) and Alzheimer’s disease (AD) patients, positive effects on oxidative stress, inflammation and mitochondrial function.

The FA study was concluded in Australia by Murdoch Childrens Research Institute in 2015 and is referenced in the AD study conducted in 2015 by a consortium, ADCS, with Professor Raymond Turner, MD, Ph.D., Georgetown, as principal investigator. Both studies have been published in scientific journals. less

Jupiter Neurosciences, Inc. (the “Company”) is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The Company incorporated in Delaware in January 2016. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL™, has many potential indications of use for rare diseases, which of we primarily are targeting Mucopolysaccharidoses Type 1, Friedreich’s Ataxi More

Deal Tracker

Stock Price